BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 12630704)

  • 1. 2,3-Butanedione monoxime (BDM) as a myosin inhibitor.
    Ostap EM
    J Muscle Res Cell Motil; 2002; 23(4):305-8. PubMed ID: 12630704
    [TBL] [Abstract][Full Text] [Related]  

  • 2. BDM (2,3-butanedione monoxime), an inhibitor of myosin-actin interaction, suppresses myofibrillogenesis in skeletal muscle cells in culture.
    Soeno Y; Shimada Y; Obinata T
    Cell Tissue Res; 1999 Feb; 295(2):307-16. PubMed ID: 9931377
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The influence of 2,3-butanedione 2-monoxime (BDM) on the interaction between actin and myosin in solution and in skinned muscle fibres.
    McKillop DF; Fortune NS; Ranatunga KW; Geeves MA
    J Muscle Res Cell Motil; 1994 Jun; 15(3):309-18. PubMed ID: 7929796
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Does 2,3-butanedione monoxime inhibit nonmuscle myosin?
    Forer A; Fabian L
    Protoplasma; 2005 Apr; 225(1-2):1-4. PubMed ID: 15868207
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The myosin ATPase inhibitor 2,3-butanedione-2-monoxime disorganizes microtubules as well as F-actin in Saccharomyces cerevisiae.
    Chon K; Hwang HS; Lee JH; Song K
    Cell Biol Toxicol; 2001; 17(6):383-93. PubMed ID: 11787860
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Skeletal muscle myosin cross-bridge cycling is necessary for myofibrillogenesis.
    Ramachandran I; Terry M; Ferrari MB
    Cell Motil Cytoskeleton; 2003 May; 55(1):61-72. PubMed ID: 12673599
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Non-specific effect of myosin inhibitor BDM on skeletal muscle contractile function].
    Yu ZB; Gao F
    Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2005 Nov; 21(4):449-52. PubMed ID: 21180172
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of myosin ATPase inhibitor 2,3-butanedione 2-monoxime on distributions of myosins, F-actin, microtubules, and cortical endoplasmic reticulum in maize root apices.
    Samaj J; Peters M; Volkmann D; Baluska F
    Plant Cell Physiol; 2000 May; 41(5):571-82. PubMed ID: 10929940
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The myosin ATPase inhibitor, 2,3-butanedione 2-monoxime, prevents protein secretion by the basidiomycete Coprinopsis cinerea.
    Hashimoto K; Yokota E; Shimmen T; Yoshida M
    Biotechnol Lett; 2011 Apr; 33(4):769-75. PubMed ID: 21165671
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the effects of 2,3-butanedione monoxime on force production, myosin light chain phosphorylation and chemical energy usage in intact and permeabilized smooth and skeletal muscles.
    Siegman MJ; Mooers SU; Warren TB; Warshaw DM; Ikebe M; Butler TM
    J Muscle Res Cell Motil; 1994 Aug; 15(4):457-72. PubMed ID: 7806639
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modulation of acto-myosin contractility in skeletal muscle myoblasts uncouples growth arrest from differentiation.
    Dhawan J; Helfman DM
    J Cell Sci; 2004 Aug; 117(Pt 17):3735-48. PubMed ID: 15252113
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Butanedione monoxime suppresses contraction and ATPase activity of rabbit skeletal muscle.
    Higuchi H; Takemori S
    J Biochem; 1989 Apr; 105(4):638-43. PubMed ID: 2527229
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interplay of troponin- and Myosin-based pathways of calcium activation in skeletal and cardiac muscle: the use of W7 as an inhibitor of thin filament activation.
    Adhikari BB; Wang K
    Biophys J; 2004 Jan; 86(1 Pt 1):359-70. PubMed ID: 14695278
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of 2,3-butanedione monoxime on myosin and myofibrillar ATPases. An example of an uncompetitive inhibitor.
    Herrmann C; Wray J; Travers F; Barman T
    Biochemistry; 1992 Dec; 31(48):12227-32. PubMed ID: 1457420
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of the myosin inhibitor 2,3-butanedione monoxime on the physiology of fission yeast.
    Steinberg G; McIntosh JR
    Eur J Cell Biol; 1998 Dec; 77(4):284-93. PubMed ID: 9930653
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modulation of IP(3)-sensitive Ca(2+) release by 2,3-butanedione monoxime.
    Turvey MR; Laude AJ; Ives EO; Seager WH; Taylor CW; Thorn P
    Pflugers Arch; 2003 Feb; 445(5):614-21. PubMed ID: 12634934
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The myosin ATPase inhibitor 2,3-butanedione-2-monoxime (BDM) inhibits tip growth and cytokinesis in the fission yeast, Schizosaccharomyces pombe.
    May KM; Wheatley SP; Amin V; Hyams JS
    Cell Motil Cytoskeleton; 1998; 41(2):117-25. PubMed ID: 9786087
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The motility of Chara corallina myosin was inhibited reversibly by 2,3-butanedione monoxime (BDM).
    Funaki K; Nagata A; Akimoto Y; Shimada K; Ito K; Yamamoto K
    Plant Cell Physiol; 2004 Sep; 45(9):1342-5. PubMed ID: 15509860
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 2,3-Butandione 2-monoxime inhibits skeletal myosin II by accelerating ATP cleavage.
    Komatsu H; Koseki Y; Kanno T; Aoki S; Kodama T
    Biochem Biophys Res Commun; 2017 Aug; 490(3):849-854. PubMed ID: 28648599
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 2,3-butanedione monoxime (BDM), a potent inhibitor of actin-myosin interaction, induces ion and fluid transport in MDCK monolayers.
    Castillo AM; Reyes JL; Sánchez E; Mondragón R; Meza I
    J Muscle Res Cell Motil; 2002; 23(3):223-34. PubMed ID: 12500902
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.